

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 5.55631485 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 5.26018885 |
| 3 | glycolipid catabolic process (GO:0019377) | 4.98816201 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.56467755 |
| 5 | ceramide catabolic process (GO:0046514) | 4.41864833 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 4.25631459 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.23167103 |
| 8 | protein carboxylation (GO:0018214) | 4.23167103 |
| 9 | amino sugar catabolic process (GO:0046348) | 4.22882091 |
| 10 | response to peptidoglycan (GO:0032494) | 4.22133288 |
| 11 | regulation of macrophage chemotaxis (GO:0010758) | 4.14631954 |
| 12 | apoptotic cell clearance (GO:0043277) | 4.03266452 |
| 13 | membrane lipid catabolic process (GO:0046466) | 4.01598406 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.95738214 |
| 15 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.95692262 |
| 16 | * cellular response to thyroid hormone stimulus (GO:0097067) | 3.88275848 |
| 17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.87690354 |
| 18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.85643376 |
| 19 | sphingolipid catabolic process (GO:0030149) | 3.80986038 |
| 20 | plasma lipoprotein particle clearance (GO:0034381) | 3.77923282 |
| 21 | eosinophil chemotaxis (GO:0048245) | 3.75940642 |
| 22 | cell adhesion mediated by integrin (GO:0033627) | 3.73490589 |
| 23 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.72479800 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 3.70948720 |
| 25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.69715499 |
| 26 | protein localization to endosome (GO:0036010) | 3.67899844 |
| 27 | barbed-end actin filament capping (GO:0051016) | 3.66220074 |
| 28 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.59942168 |
| 29 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.54263047 |
| 30 | cellular response to arsenic-containing substance (GO:0071243) | 3.52855611 |
| 31 | adhesion of symbiont to host (GO:0044406) | 3.51516450 |
| 32 | virion attachment to host cell (GO:0019062) | 3.50835512 |
| 33 | adhesion of symbiont to host cell (GO:0044650) | 3.50835512 |
| 34 | regulation of cholesterol storage (GO:0010885) | 3.48514889 |
| 35 | basement membrane organization (GO:0071711) | 3.46641188 |
| 36 | monocyte chemotaxis (GO:0002548) | 3.46256588 |
| 37 | regulation of protein activation cascade (GO:2000257) | 3.46187192 |
| 38 | fibrinolysis (GO:0042730) | 3.44743111 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.44677804 |
| 40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.44630035 |
| 41 | positive regulation of cholesterol efflux (GO:0010875) | 3.43113196 |
| 42 | regulation of monocyte chemotaxis (GO:0090025) | 3.41701553 |
| 43 | regulation of complement activation (GO:0030449) | 3.41038778 |
| 44 | L-phenylalanine catabolic process (GO:0006559) | 3.36812429 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.36812429 |
| 46 | eosinophil migration (GO:0072677) | 3.31350074 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.31235287 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.30626485 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30128299 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 3.30128299 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.27807177 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.23556138 |
| 53 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22348963 |
| 54 | * response to thyroid hormone (GO:0097066) | 3.20249639 |
| 55 | cysteine metabolic process (GO:0006534) | 3.20164395 |
| 56 | regulation of podosome assembly (GO:0071801) | 3.19897020 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 3.19469438 |
| 58 | sulfur amino acid catabolic process (GO:0000098) | 3.11991561 |
| 59 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.10304393 |
| 60 | positive regulation of hemostasis (GO:1900048) | 3.08984219 |
| 61 | positive regulation of blood coagulation (GO:0030194) | 3.08984219 |
| 62 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.08883649 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 3.06145953 |
| 64 | positive regulation of leukocyte degranulation (GO:0043302) | 3.06145089 |
| 65 | complement activation, alternative pathway (GO:0006957) | 3.05814825 |
| 66 | decidualization (GO:0046697) | 3.05765016 |
| 67 | regulation of chemokine biosynthetic process (GO:0045073) | 3.05539239 |
| 68 | regulation of fibrinolysis (GO:0051917) | 3.04370934 |
| 69 | alpha-linolenic acid metabolic process (GO:0036109) | 3.02183870 |
| 70 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.00718855 |
| 71 | phagosome maturation (GO:0090382) | 2.98199937 |
| 72 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97150070 |
| 73 | glial cell migration (GO:0008347) | 2.96391763 |
| 74 | iron ion import (GO:0097286) | 2.96341947 |
| 75 | pinocytosis (GO:0006907) | 2.92367090 |
| 76 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90873232 |
| 77 | positive regulation of coagulation (GO:0050820) | 2.90565328 |
| 78 | positive regulation of cholesterol transport (GO:0032376) | 2.90203314 |
| 79 | positive regulation of sterol transport (GO:0032373) | 2.90203314 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 2.88323210 |
| 81 | cellular response to cadmium ion (GO:0071276) | 2.88190539 |
| 82 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.87356528 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85622900 |
| 84 | glyoxylate metabolic process (GO:0046487) | 2.83305099 |
| 85 | lipoprotein metabolic process (GO:0042157) | 2.83099568 |
| 86 | wound healing, spreading of epidermal cells (GO:0035313) | 2.80981200 |
| 87 | aldehyde catabolic process (GO:0046185) | 2.80976816 |
| 88 | hyaluronan catabolic process (GO:0030214) | 2.80197902 |
| 89 | vitamin transmembrane transport (GO:0035461) | 2.77017731 |
| 90 | cellular response to lipopolysaccharide (GO:0071222) | 2.76349441 |
| 91 | folic acid transport (GO:0015884) | 2.75975618 |
| 92 | homocysteine metabolic process (GO:0050667) | 2.74549344 |
| 93 | cellular response to zinc ion (GO:0071294) | 2.74449629 |
| 94 | endodermal cell differentiation (GO:0035987) | 2.72587088 |
| 95 | cellular response to interferon-alpha (GO:0035457) | 2.72511710 |
| 96 | intracellular pH reduction (GO:0051452) | 2.71837749 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.70912535 |
| 98 | cholesterol efflux (GO:0033344) | 2.70235642 |
| 99 | lymphangiogenesis (GO:0001946) | 2.70036712 |
| 100 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69987775 |
| 101 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.69700069 |
| 102 | sphingosine metabolic process (GO:0006670) | 2.69173050 |
| 103 | skin morphogenesis (GO:0043589) | 2.68211962 |
| 104 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.67426933 |
| 105 | positive regulation of extracellular matrix organization (GO:1903055) | 2.67097468 |
| 106 | cellular response to molecule of bacterial origin (GO:0071219) | 2.65105269 |
| 107 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.64431298 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 2.64334056 |
| 109 | vitamin D metabolic process (GO:0042359) | 2.62174793 |
| 110 | pH reduction (GO:0045851) | 2.62072104 |
| 111 | phospholipid efflux (GO:0033700) | 2.61595247 |
| 112 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61308395 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 2.61307300 |
| 114 | protein-lipid complex remodeling (GO:0034368) | 2.61307300 |
| 115 | macromolecular complex remodeling (GO:0034367) | 2.61307300 |
| 116 | wound healing, spreading of cells (GO:0044319) | 2.61274195 |
| 117 | 4-hydroxyproline metabolic process (GO:0019471) | 2.60924617 |
| 118 | keratan sulfate catabolic process (GO:0042340) | 2.60484287 |
| 119 | aromatic amino acid family catabolic process (GO:0009074) | 2.59968707 |
| 120 | phospholipid homeostasis (GO:0055091) | 2.59382866 |
| 121 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.59347432 |
| 122 | regulation of superoxide anion generation (GO:0032928) | 2.59066103 |
| 123 | protein-lipid complex assembly (GO:0065005) | 2.57980709 |
| 124 | serine family amino acid catabolic process (GO:0009071) | 2.57898250 |
| 125 | macrophage differentiation (GO:0030225) | 2.55947510 |
| 126 | positive regulation of p38MAPK cascade (GO:1900745) | 2.55667739 |
| 127 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.54987902 |
| 128 | cellular extravasation (GO:0045123) | 2.54351044 |
| 129 | epoxygenase P450 pathway (GO:0019373) | 2.53547373 |
| 130 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.53141326 |
| 131 | response to lipoprotein particle (GO:0055094) | 2.52901109 |
| 132 | positive regulation of leukocyte migration (GO:0002687) | 2.52241138 |
| 133 | immunoglobulin mediated immune response (GO:0016064) | 2.52113482 |
| 134 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.52022818 |
| 135 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.52022818 |
| 136 | cellular response to vitamin (GO:0071295) | 2.51784962 |
| 137 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.51222185 |
| 138 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.50940922 |
| 139 | transferrin transport (GO:0033572) | 2.50760825 |
| 140 | positive regulation of heat generation (GO:0031652) | 2.50719949 |
| 141 | response to progesterone (GO:0032570) | 2.50584703 |
| 142 | osteoclast differentiation (GO:0030316) | 2.50225238 |
| 143 | negative regulation of protein activation cascade (GO:2000258) | 2.50155161 |
| 144 | low-density lipoprotein particle remodeling (GO:0034374) | 2.49860157 |
| 145 | lytic vacuole organization (GO:0080171) | 2.49715448 |
| 146 | lysosome organization (GO:0007040) | 2.49715448 |
| 147 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.48127391 |
| 148 | negative regulation of blood coagulation (GO:0030195) | 2.47899635 |
| 149 | negative regulation of hemostasis (GO:1900047) | 2.47899635 |
| 150 | negative regulation of coagulation (GO:0050819) | 2.47834882 |
| 151 | bile acid biosynthetic process (GO:0006699) | 2.47411397 |
| 152 | hemidesmosome assembly (GO:0031581) | 2.46300039 |
| 153 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.45781191 |
| 154 | cholesterol transport (GO:0030301) | 2.45385174 |
| 155 | sterol transport (GO:0015918) | 2.45385174 |
| 156 | opsonization (GO:0008228) | 2.44934105 |
| 157 | xenobiotic catabolic process (GO:0042178) | 2.44643111 |
| 158 | urea cycle (GO:0000050) | 2.44447251 |
| 159 | urea metabolic process (GO:0019627) | 2.44447251 |
| 160 | transcytosis (GO:0045056) | 2.43940915 |
| 161 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.43345568 |
| 162 | glomerular basement membrane development (GO:0032836) | 2.42822989 |
| 163 | regulation of mononuclear cell migration (GO:0071675) | 2.41899058 |
| 164 | * extracellular matrix disassembly (GO:0022617) | 2.39770354 |
| 165 | * collagen metabolic process (GO:0032963) | 2.39383513 |
| 166 | L-ascorbic acid metabolic process (GO:0019852) | 2.39051538 |
| 167 | sexual reproduction (GO:0019953) | 2.38200463 |
| 168 | sterol homeostasis (GO:0055092) | 2.37956567 |
| 169 | triglyceride homeostasis (GO:0070328) | 2.37937196 |
| 170 | acylglycerol homeostasis (GO:0055090) | 2.37937196 |
| 171 | response to nitrosative stress (GO:0051409) | 2.37772878 |
| 172 | negative regulation of lipid storage (GO:0010888) | 2.36771694 |
| 173 | protein-lipid complex subunit organization (GO:0071825) | 2.36465674 |
| 174 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36286151 |
| 175 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36286151 |
| 176 | modulation by symbiont of host immune response (GO:0052553) | 2.36286151 |
| 177 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36286151 |
| 178 | modulation by symbiont of host defense response (GO:0052031) | 2.36286151 |
| 179 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36286151 |
| 180 | COPI coating of Golgi vesicle (GO:0048205) | 2.35917890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.74786711 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25076631 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.91724294 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.91066653 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.75930154 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.71851964 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.67724040 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57513018 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.51643658 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.49473380 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.52119830 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45745740 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.43432284 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.41473620 |
| 15 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.36517863 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31670493 |
| 17 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.26741609 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22048151 |
| 19 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.14866370 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.13545032 |
| 21 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12378523 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.12197820 |
| 23 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.11219867 |
| 24 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.09913913 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.05798818 |
| 26 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02586890 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95495702 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94055509 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.88972200 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87658737 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84406593 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84195818 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83140160 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.82311689 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.82311689 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80130543 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79427699 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78319810 |
| 39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.77040949 |
| 40 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.72782961 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69906589 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.69448657 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67763254 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.64976477 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64815054 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61547628 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60596451 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59647475 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.57946747 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56011944 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55082275 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54613690 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.51850087 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51842456 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50957399 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50212007 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50205415 |
| 58 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48921548 |
| 59 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.47351881 |
| 60 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.47351881 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45581167 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42882440 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41911852 |
| 64 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40254812 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38836476 |
| 66 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.36945774 |
| 67 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.36945774 |
| 68 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.36945774 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35700265 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35573735 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35483120 |
| 72 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34520999 |
| 73 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.32135717 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30354848 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30298740 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29918339 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29819222 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27649689 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27041305 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26410353 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25565704 |
| 82 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24425859 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24126729 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23882445 |
| 85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23148478 |
| 86 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.22652862 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22377541 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18534969 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18448935 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17776096 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17527393 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17411169 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17394325 |
| 94 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.16979150 |
| 95 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16963100 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16658911 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15727768 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14424643 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14049911 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13875634 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12167082 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11998954 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10547529 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10500891 |
| 105 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.10018325 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07851006 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07734113 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07351296 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06768491 |
| 110 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06516828 |
| 111 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06040448 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05344709 |
| 113 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04898799 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04889113 |
| 115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03982369 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02728431 |
| 117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01762062 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98059662 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97135184 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96743538 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96440193 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96227978 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96045143 |
| 124 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96014068 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95700652 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95485329 |
| 127 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93508708 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92375485 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90959052 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90279165 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89941555 |
| 132 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.89895128 |
| 133 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89803778 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88717462 |
| 135 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88365775 |
| 136 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.87332122 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86785465 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85862114 |
| 139 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85074707 |
| 140 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84554045 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82860083 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80688390 |
| 143 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76943828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.81387011 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.45106606 |
| 3 | MP0009840_abnormal_foam_cell | 3.17663824 |
| 4 | MP0003195_calcinosis | 3.03267693 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.01565235 |
| 6 | MP0004272_abnormal_basement_membrane | 2.95996396 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.93119217 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.86300850 |
| 9 | MP0005360_urolithiasis | 2.67529710 |
| 10 | MP0005275_abnormal_skin_tensile | 2.52031101 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.51945780 |
| 12 | MP0004510_myositis | 2.44143142 |
| 13 | MP0009785_altered_susceptibility_to | 2.37133424 |
| 14 | MP0005365_abnormal_bile_salt | 2.25047870 |
| 15 | MP0006054_spinal_hemorrhage | 2.23398066 |
| 16 | MP0003075_altered_response_to | 2.17734707 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.07734975 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.02634125 |
| 19 | MP0002254_reproductive_system_inflammat | 1.98996919 |
| 20 | MP0001853_heart_inflammation | 1.90421994 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.89593292 |
| 22 | MP0003329_amyloid_beta_deposits | 1.87802392 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.83033180 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.81339920 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.80275903 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.74870652 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.73504218 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.72400318 |
| 29 | MP0005025_abnormal_response_to | 1.71414204 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.69935512 |
| 31 | MP0003690_abnormal_glial_cell | 1.68720800 |
| 32 | MP0001661_extended_life_span | 1.67962825 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66124282 |
| 34 | MP0001790_abnormal_immune_system | 1.64506343 |
| 35 | MP0005387_immune_system_phenotype | 1.64506343 |
| 36 | MP0001958_emphysema | 1.64327327 |
| 37 | * MP0005000_abnormal_immune_tolerance | 1.64309094 |
| 38 | MP0000604_amyloidosis | 1.63215377 |
| 39 | MP0005023_abnormal_wound_healing | 1.62913982 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.60356629 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.50458354 |
| 42 | MP0003724_increased_susceptibility_to | 1.50032981 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.49202052 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.48767149 |
| 45 | MP0005083_abnormal_biliary_tract | 1.48004491 |
| 46 | MP0005332_abnormal_amino_acid | 1.47499230 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.46756257 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.46431359 |
| 49 | * MP0002452_abnormal_antigen_presenting | 1.43996960 |
| 50 | MP0005671_abnormal_response_to | 1.43800012 |
| 51 | MP0001542_abnormal_bone_strength | 1.43704959 |
| 52 | MP0003252_abnormal_bile_duct | 1.42494639 |
| 53 | MP0000685_abnormal_immune_system | 1.41512894 |
| 54 | MP0003279_aneurysm | 1.38790200 |
| 55 | MP0006082_CNS_inflammation | 1.37994646 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.36618528 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.34291474 |
| 58 | * MP0001845_abnormal_inflammatory_respons | 1.33758040 |
| 59 | MP0000920_abnormal_myelination | 1.30935371 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.26087168 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.26087168 |
| 62 | MP0002723_abnormal_immune_serum | 1.25476548 |
| 63 | MP0002060_abnormal_skin_morphology | 1.22586168 |
| 64 | MP0000343_altered_response_to | 1.22552700 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.21894239 |
| 66 | * MP0000609_abnormal_liver_physiology | 1.20689588 |
| 67 | MP0005164_abnormal_response_to | 1.20672386 |
| 68 | MP0002168_other_aberrant_phenotype | 1.20600907 |
| 69 | MP0008260_abnormal_autophagy | 1.20461449 |
| 70 | MP0003091_abnormal_cell_migration | 1.20292931 |
| 71 | MP0005166_decreased_susceptibility_to | 1.18953914 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.18846664 |
| 73 | MP0002405_respiratory_system_inflammati | 1.17195857 |
| 74 | MP0005508_abnormal_skeleton_morphology | 1.12825982 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 1.11722532 |
| 76 | MP0003828_pulmonary_edema | 1.10143140 |
| 77 | MP0000371_diluted_coat_color | 1.10006460 |
| 78 | MP0003186_abnormal_redox_activity | 1.10001715 |
| 79 | * MP0004947_skin_inflammation | 1.08293641 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 1.08152301 |
| 81 | MP0001666_abnormal_nutrient_absorption | 1.07847281 |
| 82 | MP0005451_abnormal_body_composition | 1.07138086 |
| 83 | MP0009643_abnormal_urine_homeostasis | 1.04412499 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 1.04159316 |
| 85 | MP0005165_increased_susceptibility_to | 1.04083458 |
| 86 | MP0003303_peritoneal_inflammation | 1.03611738 |
| 87 | MP0001756_abnormal_urination | 1.03245962 |
| 88 | MP0001915_intracranial_hemorrhage | 1.02629138 |
| 89 | MP0005595_abnormal_vascular_smooth | 1.02004857 |
| 90 | MP0005408_hypopigmentation | 1.01498398 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 1.01028373 |
| 92 | MP0002896_abnormal_bone_mineralization | 1.00930726 |
| 93 | MP0001851_eye_inflammation | 0.99608219 |
| 94 | MP0004130_abnormal_muscle_cell | 0.98595721 |
| 95 | * MP0001819_abnormal_immune_cell | 0.96763256 |
| 96 | * MP0002420_abnormal_adaptive_immunity | 0.96187931 |
| 97 | MP0003436_decreased_susceptibility_to | 0.93217197 |
| 98 | MP0008004_abnormal_stomach_pH | 0.93082060 |
| 99 | MP0000733_abnormal_muscle_development | 0.92891910 |
| 100 | MP0000598_abnormal_liver_morphology | 0.92238398 |
| 101 | MP0005395_other_phenotype | 0.91879795 |
| 102 | MP0005390_skeleton_phenotype | 0.91768597 |
| 103 | MP0001800_abnormal_humoral_immune | 0.91018050 |
| 104 | MP0003634_abnormal_glial_cell | 0.90907891 |
| 105 | MP0004233_abnormal_muscle_weight | 0.89341967 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.89296346 |
| 107 | MP0009053_abnormal_anal_canal | 0.88991705 |
| 108 | * MP0003453_abnormal_keratinocyte_physiol | 0.88804219 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.88499457 |
| 110 | MP0009278_abnormal_bone_marrow | 0.88033646 |
| 111 | * MP0003795_abnormal_bone_structure | 0.86281420 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.85585591 |
| 113 | MP0010307_abnormal_tumor_latency | 0.83869779 |
| 114 | MP0004883_abnormal_blood_vessel | 0.81081330 |
| 115 | MP0009763_increased_sensitivity_to | 0.80989270 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.80415848 |
| 117 | MP0005197_abnormal_uvea_morphology | 0.79625946 |
| 118 | MP0003448_altered_tumor_morphology | 0.78335241 |
| 119 | * MP0002998_abnormal_bone_remodeling | 0.78198081 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.77819539 |
| 121 | MP0001849_ear_inflammation | 0.77486540 |
| 122 | MP0009764_decreased_sensitivity_to | 0.77302074 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.76976957 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.76337721 |
| 125 | MP0000249_abnormal_blood_vessel | 0.75847314 |
| 126 | MP0005647_abnormal_sex_gland | 0.75524216 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74290769 |
| 128 | MP0002090_abnormal_vision | 0.74142284 |
| 129 | MP0002796_impaired_skin_barrier | 0.74012112 |
| 130 | MP0008469_abnormal_protein_level | 0.73671509 |
| 131 | MP0005670_abnormal_white_adipose | 0.72807388 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.72756986 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.72046864 |
| 134 | MP0005367_renal/urinary_system_phenotyp | 0.71917452 |
| 135 | MP0000516_abnormal_urinary_system | 0.71917452 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.71367635 |
| 137 | MP0000858_altered_metastatic_potential | 0.71344714 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.71121349 |
| 139 | MP0001881_abnormal_mammary_gland | 0.70058892 |
| 140 | MP0003045_fibrosis | 0.69744411 |
| 141 | * MP0002419_abnormal_innate_immunity | 0.69146064 |
| 142 | MP0003950_abnormal_plasma_membrane | 0.68592068 |
| 143 | * MP0001243_abnormal_dermal_layer | 0.68404640 |
| 144 | * MP0005310_abnormal_salivary_gland | 0.66793493 |
| 145 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62193330 |
| 146 | MP0000747_muscle_weakness | 0.60347271 |
| 147 | MP0008874_decreased_physiological_sensi | 0.58724801 |
| 148 | MP0003632_abnormal_nervous_system | 0.58649484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.04389941 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.74482655 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.51425233 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.29473472 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.03557670 |
| 6 | Disinhibition (HP:0000734) | 4.00460738 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.99165451 |
| 8 | Xanthomatosis (HP:0000991) | 3.72891623 |
| 9 | Nuclear cataract (HP:0100018) | 3.63262151 |
| 10 | Mutism (HP:0002300) | 3.58269938 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.55859445 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.52760774 |
| 13 | Myocardial infarction (HP:0001658) | 3.50226900 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.47645477 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47204939 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.44340429 |
| 17 | Complement deficiency (HP:0004431) | 3.35355987 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.33447266 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.30247698 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.21311287 |
| 21 | Osteolytic defects of the hand bones (HP:0009699) | 3.20245543 |
| 22 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.20245543 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10902054 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10902054 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10902054 |
| 26 | Nonimmune hydrops fetalis (HP:0001790) | 3.09928363 |
| 27 | Cerebral aneurysm (HP:0004944) | 3.07316068 |
| 28 | Ankle contracture (HP:0006466) | 3.05341203 |
| 29 | Cervical subluxation (HP:0003308) | 3.03019793 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.98612708 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.98571945 |
| 32 | Axonal loss (HP:0003447) | 2.94022179 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.93214085 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.93214085 |
| 35 | Glomerulonephritis (HP:0000099) | 2.90040040 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 2.84741277 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.84217261 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.83942273 |
| 39 | Apathy (HP:0000741) | 2.82353750 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81433751 |
| 41 | Diminished motivation (HP:0000745) | 2.79798690 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.79082088 |
| 43 | Abnormality of complement system (HP:0005339) | 2.69365184 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68651449 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68651449 |
| 46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68651449 |
| 47 | Progressive neurologic deterioration (HP:0002344) | 2.62998608 |
| 48 | Metaphyseal irregularity (HP:0003025) | 2.61830889 |
| 49 | Nephritis (HP:0000123) | 2.58729801 |
| 50 | Upper motor neuron abnormality (HP:0002127) | 2.57755994 |
| 51 | Neuronal loss in central nervous system (HP:0002529) | 2.57076498 |
| 52 | Peritonitis (HP:0002586) | 2.56016392 |
| 53 | Skin nodule (HP:0200036) | 2.55138359 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.53437851 |
| 55 | Aortic dissection (HP:0002647) | 2.51354613 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51310007 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.50082589 |
| 58 | Purpura (HP:0000979) | 2.48287384 |
| 59 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47656597 |
| 60 | Increased serum ferritin (HP:0003281) | 2.46100842 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.45974471 |
| 62 | Hydroxyprolinuria (HP:0003080) | 2.43883332 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.43883332 |
| 64 | Soft skin (HP:0000977) | 2.43542563 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.42621706 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.42590103 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.42523476 |
| 68 | Alopecia of scalp (HP:0002293) | 2.38113326 |
| 69 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37702789 |
| 70 | Blue sclerae (HP:0000592) | 2.37323771 |
| 71 | Thick nail (HP:0001805) | 2.36950044 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.36113634 |
| 73 | Broad metatarsal (HP:0001783) | 2.35053352 |
| 74 | Short nail (HP:0001799) | 2.34982596 |
| 75 | Joint hemorrhage (HP:0005261) | 2.31254087 |
| 76 | Atrophic scars (HP:0001075) | 2.30122302 |
| 77 | Aortic aneurysm (HP:0004942) | 2.24839291 |
| 78 | Shallow orbits (HP:0000586) | 2.24837698 |
| 79 | Esophageal varix (HP:0002040) | 2.24728744 |
| 80 | Vascular calcification (HP:0004934) | 2.24307423 |
| 81 | Conjunctival telangiectasia (HP:0000524) | 2.23752881 |
| 82 | Vascular tortuosity (HP:0004948) | 2.23034163 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22531555 |
| 84 | Dementia (HP:0000726) | 2.21181374 |
| 85 | Prolonged partial thromboplastin time (HP:0003645) | 2.20789148 |
| 86 | Supranuclear gaze palsy (HP:0000605) | 2.17700480 |
| 87 | Hypobetalipoproteinemia (HP:0003563) | 2.17415970 |
| 88 | Arterial tortuosity (HP:0005116) | 2.16954287 |
| 89 | Agnosia (HP:0010524) | 2.12781262 |
| 90 | Ovoid vertebral bodies (HP:0003300) | 2.10913749 |
| 91 | Wormian bones (HP:0002645) | 2.10858761 |
| 92 | Nausea (HP:0002018) | 2.10375345 |
| 93 | Cardiomegaly (HP:0001640) | 2.07580220 |
| 94 | Global brain atrophy (HP:0002283) | 2.07493190 |
| 95 | Retinal atrophy (HP:0001105) | 2.07427217 |
| 96 | Abnormality of the periventricular white matter (HP:0002518) | 2.06678585 |
| 97 | Hyperglycinemia (HP:0002154) | 2.06607423 |
| 98 | Bone pain (HP:0002653) | 2.06246270 |
| 99 | Mitral stenosis (HP:0001718) | 2.05747954 |
| 100 | Inappropriate behavior (HP:0000719) | 2.04656892 |
| 101 | Lymphangioma (HP:0100764) | 2.01826699 |
| 102 | Peripheral demyelination (HP:0011096) | 2.00655456 |
| 103 | Abnormal delivery (HP:0001787) | 2.00544087 |
| 104 | Increased CSF protein (HP:0002922) | 2.00164447 |
| 105 | Orchitis (HP:0100796) | 1.99833142 |
| 106 | Hypercholesterolemia (HP:0003124) | 1.96804169 |
| 107 | Epidermoid cyst (HP:0200040) | 1.96600478 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.94237301 |
| 109 | Fat malabsorption (HP:0002630) | 1.94053439 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93913216 |
| 111 | Focal segmental glomerulosclerosis (HP:0000097) | 1.92985040 |
| 112 | Hypoglycemic coma (HP:0001325) | 1.92532622 |
| 113 | Protuberant abdomen (HP:0001538) | 1.90945599 |
| 114 | Tetraparesis (HP:0002273) | 1.90854693 |
| 115 | Beaking of vertebral bodies (HP:0004568) | 1.90237773 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.90235353 |
| 117 | Hyperglycinuria (HP:0003108) | 1.89133313 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.88904048 |
| 119 | Hemorrhage of the eye (HP:0011885) | 1.87292264 |
| 120 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86894664 |
| 121 | Abnormality of glycine metabolism (HP:0010895) | 1.86894664 |
| 122 | Right ventricular cardiomyopathy (HP:0011663) | 1.86800879 |
| 123 | Esophageal neoplasm (HP:0100751) | 1.85963134 |
| 124 | Neoplasm of head and neck (HP:0012288) | 1.85963134 |
| 125 | Spondylolisthesis (HP:0003302) | 1.84015714 |
| 126 | Loss of speech (HP:0002371) | 1.83628908 |
| 127 | Hematochezia (HP:0002573) | 1.83497787 |
| 128 | Personality changes (HP:0000751) | 1.82590606 |
| 129 | Aneurysm (HP:0002617) | 1.81312285 |
| 130 | Pathologic fracture (HP:0002756) | 1.81311286 |
| 131 | Malnutrition (HP:0004395) | 1.81180627 |
| 132 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80996697 |
| 133 | Gingivitis (HP:0000230) | 1.80690649 |
| 134 | Increased connective tissue (HP:0009025) | 1.80683795 |
| 135 | Turricephaly (HP:0000262) | 1.80663040 |
| 136 | Joint stiffness (HP:0001387) | 1.80618850 |
| 137 | Mesangial abnormality (HP:0001966) | 1.78480253 |
| 138 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.77242871 |
| 139 | Follicular hyperkeratosis (HP:0007502) | 1.76655526 |
| 140 | Petechiae (HP:0000967) | 1.75522397 |
| 141 | Amyloidosis (HP:0011034) | 1.75271753 |
| 142 | Asymmetric septal hypertrophy (HP:0001670) | 1.74280856 |
| 143 | Hand muscle atrophy (HP:0009130) | 1.74278558 |
| 144 | J-shaped sella turcica (HP:0002680) | 1.74048868 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.72302334 |
| 146 | Optic neuritis (HP:0100653) | 1.72302334 |
| 147 | Obstructive lung disease (HP:0006536) | 1.70017702 |
| 148 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70017702 |
| 149 | Achilles tendon contracture (HP:0001771) | 1.68886315 |
| 150 | Myositis (HP:0100614) | 1.68757816 |
| 151 | Recurrent skin infections (HP:0001581) | 1.66596947 |
| 152 | Thin bony cortex (HP:0002753) | 1.65350048 |
| 153 | Progressive visual loss (HP:0000529) | 1.62990900 |
| 154 | Albinism (HP:0001022) | 1.62023870 |
| 155 | Polyneuropathy (HP:0001271) | 1.61478124 |
| 156 | Thoracic kyphosis (HP:0002942) | 1.61128997 |
| 157 | Pulmonary infiltrates (HP:0002113) | 1.60803420 |
| 158 | Basal ganglia calcification (HP:0002135) | 1.59472338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.06442107 |
| 2 | ERN1 | 3.69664816 |
| 3 | GRK7 | 3.30871172 |
| 4 | TRIB3 | 3.13382689 |
| 5 | EPHB1 | 2.93949300 |
| 6 | MAP3K14 | 2.53172690 |
| 7 | TGFBR2 | 2.47866937 |
| 8 | EPHA2 | 2.33204016 |
| 9 | LATS1 | 2.31938267 |
| 10 | TAOK2 | 2.26440221 |
| 11 | MATK | 2.21506539 |
| 12 | NEK9 | 2.19927930 |
| 13 | ACVR1B | 2.17414172 |
| 14 | PKN2 | 2.06433167 |
| 15 | FGFR4 | 2.00505862 |
| 16 | PBK | 1.96705917 |
| 17 | LATS2 | 1.93868828 |
| 18 | MET | 1.93105682 |
| 19 | TTN | 1.89517945 |
| 20 | DDR2 | 1.84631219 |
| 21 | PDGFRA | 1.81678208 |
| 22 | FGR | 1.80716308 |
| 23 | SCYL2 | 1.69855385 |
| 24 | PTK6 | 1.67566053 |
| 25 | PTK2 | 1.62811369 |
| 26 | PRPF4B | 1.58052037 |
| 27 | FER | 1.57706831 |
| 28 | STK3 | 1.54636834 |
| 29 | CDC42BPA | 1.52344804 |
| 30 | MAP3K11 | 1.47614353 |
| 31 | RIPK1 | 1.45405402 |
| 32 | MAP3K3 | 1.45087519 |
| 33 | SIK1 | 1.43229723 |
| 34 | PAK4 | 1.39334108 |
| 35 | TIE1 | 1.37323511 |
| 36 | ERBB4 | 1.36786955 |
| 37 | ADRBK2 | 1.33477034 |
| 38 | PAK2 | 1.33273939 |
| 39 | EPHB2 | 1.31674992 |
| 40 | FRK | 1.30457379 |
| 41 | LIMK1 | 1.29883317 |
| 42 | MST1R | 1.29381373 |
| 43 | IKBKB | 1.27549871 |
| 44 | ABL2 | 1.27464482 |
| 45 | MAPK15 | 1.25840398 |
| 46 | JAK1 | 1.22964146 |
| 47 | BCKDK | 1.22845789 |
| 48 | ZAP70 | 1.20728924 |
| 49 | TBK1 | 1.17468732 |
| 50 | TAOK1 | 1.17187455 |
| 51 | EPHA3 | 1.17033760 |
| 52 | TYK2 | 1.16595029 |
| 53 | MAP2K2 | 1.13574952 |
| 54 | NME2 | 1.13060258 |
| 55 | LRRK2 | 1.12197389 |
| 56 | MAP2K1 | 1.11183748 |
| 57 | PIK3CG | 1.09122212 |
| 58 | MAP3K2 | 1.08256640 |
| 59 | IRAK4 | 1.08086756 |
| 60 | BMX | 1.07736389 |
| 61 | BMPR2 | 1.06393721 |
| 62 | MAP3K13 | 1.06185759 |
| 63 | CAMKK2 | 1.01674650 |
| 64 | STK39 | 0.99594913 |
| 65 | STK38L | 0.97116522 |
| 66 | PAK3 | 0.95421614 |
| 67 | MAP3K1 | 0.92513705 |
| 68 | MOS | 0.91663394 |
| 69 | TYRO3 | 0.90714939 |
| 70 | PDK2 | 0.90647071 |
| 71 | PIM2 | 0.90424788 |
| 72 | NTRK1 | 0.88612478 |
| 73 | PDGFRB | 0.85690367 |
| 74 | IKBKE | 0.82507998 |
| 75 | RIPK4 | 0.82223039 |
| 76 | WNK4 | 0.80812268 |
| 77 | GSK3A | 0.80668384 |
| 78 | BLK | 0.77881781 |
| 79 | CSK | 0.75888971 |
| 80 | KSR2 | 0.75667382 |
| 81 | TRPM7 | 0.74784417 |
| 82 | FGFR2 | 0.74645192 |
| 83 | TESK1 | 0.74166114 |
| 84 | RPS6KA4 | 0.73858568 |
| 85 | JAK2 | 0.73652230 |
| 86 | ARAF | 0.72567231 |
| 87 | STK10 | 0.72123821 |
| 88 | CHUK | 0.70678835 |
| 89 | CAMK1D | 0.70646104 |
| 90 | CLK1 | 0.69074435 |
| 91 | TESK2 | 0.68784213 |
| 92 | MTOR | 0.68642412 |
| 93 | CSNK1A1L | 0.68536348 |
| 94 | IRAK2 | 0.68080354 |
| 95 | FGFR1 | 0.67058548 |
| 96 | MARK3 | 0.66247874 |
| 97 | TGFBR1 | 0.64183526 |
| 98 | MAP2K3 | 0.61588080 |
| 99 | MAP3K5 | 0.61562231 |
| 100 | CSF1R | 0.59612535 |
| 101 | WNK3 | 0.59411251 |
| 102 | CDK6 | 0.57204459 |
| 103 | STK24 | 0.57004779 |
| 104 | EGFR | 0.54811072 |
| 105 | PTK2B | 0.54435989 |
| 106 | RET | 0.54225377 |
| 107 | CSNK1G1 | 0.53907961 |
| 108 | LYN | 0.53635901 |
| 109 | PRKG2 | 0.53281324 |
| 110 | CSNK1G3 | 0.50362788 |
| 111 | RPS6KC1 | 0.48317066 |
| 112 | RPS6KL1 | 0.48317066 |
| 113 | RPS6KA2 | 0.48237619 |
| 114 | ABL1 | 0.48195961 |
| 115 | BRSK2 | 0.46743282 |
| 116 | KIT | 0.46288050 |
| 117 | PDPK1 | 0.45273985 |
| 118 | PAK1 | 0.43501669 |
| 119 | FLT3 | 0.43200397 |
| 120 | IGF1R | 0.42772518 |
| 121 | MST4 | 0.42152403 |
| 122 | MAP3K8 | 0.40488573 |
| 123 | ICK | 0.39721779 |
| 124 | INSR | 0.39573499 |
| 125 | ERBB2 | 0.36429420 |
| 126 | ROCK1 | 0.36417667 |
| 127 | FGFR3 | 0.36411071 |
| 128 | MAPK4 | 0.36200905 |
| 129 | MYLK | 0.36062822 |
| 130 | JAK3 | 0.35791501 |
| 131 | MAP2K6 | 0.34286800 |
| 132 | CAMK2G | 0.33998530 |
| 133 | IRAK3 | 0.33978199 |
| 134 | IRAK1 | 0.32928866 |
| 135 | DAPK3 | 0.32257637 |
| 136 | PAK6 | 0.31778333 |
| 137 | RPS6KA6 | 0.31648774 |
| 138 | PRKD1 | 0.31317692 |
| 139 | EIF2AK3 | 0.30572784 |
| 140 | HCK | 0.26423390 |
| 141 | MAP3K12 | 0.25723035 |
| 142 | PRKD2 | 0.25535524 |
| 143 | LCK | 0.25084879 |
| 144 | DAPK2 | 0.22554122 |
| 145 | PRKCD | 0.22074416 |
| 146 | CAMK1G | 0.21510617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.16267716 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58618845 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 2.55135504 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48150813 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.31460022 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28151148 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27633957 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.27323722 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.18515431 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.10212124 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.96404534 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.87222970 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86389888 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85145287 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81605408 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76848960 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.75220741 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70525358 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 1.67692244 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.65134769 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64324587 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63616093 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.58681066 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58520627 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54184299 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.53325783 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.53317770 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51055460 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.47246685 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46910668 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.44874609 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44430160 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41284706 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40791631 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40338071 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38488127 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37257345 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36779622 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32087505 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30975869 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27615957 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26302786 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24466136 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.24069259 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22462015 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21382587 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17715923 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14516228 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12989856 |
| 50 | * Phagosome_Homo sapiens_hsa04145 | 1.09996264 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07566338 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.06505268 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05947916 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05877411 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05562923 |
| 56 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04202568 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.04077283 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03689987 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02729309 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.01563055 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99580582 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97364662 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96412251 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95697150 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95358838 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95356564 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95064857 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94876622 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.92386858 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.92019048 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89859740 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88137183 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87604530 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85515912 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84098662 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83443176 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83042324 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81623620 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.80189306 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78554786 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77727761 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77653236 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77213068 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76482779 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.74624132 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.74445284 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73953414 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73898546 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73502294 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73129726 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72502992 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72084371 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71654627 |
| 94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71183908 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70949049 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68891186 |
| 97 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66669913 |
| 98 | * Apoptosis_Homo sapiens_hsa04210 | 0.66008227 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.65123523 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64998527 |
| 101 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64586830 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.63608066 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63313362 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61311106 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60813354 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58975838 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58579751 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58452531 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58193323 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.57806115 |
| 111 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57248345 |
| 112 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55314151 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.54735043 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54163105 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53926651 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53809998 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52882207 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52519123 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52470047 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52151208 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52045597 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51014535 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49535359 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49123695 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48973645 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.48960847 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45839872 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44908386 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44711769 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.43487896 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43219034 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.42497137 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42145270 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.42127226 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40524797 |
| 136 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40189177 |
| 137 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39433181 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.38803202 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38676313 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.38405351 |
| 141 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37628547 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30668207 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30608575 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26904378 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24180850 |
| 146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23978945 |
| 147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21004716 |
| 148 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21002146 |
| 149 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.18988188 |
| 150 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16861871 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15266208 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12397425 |
| 153 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.12356725 |
| 154 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12030431 |
| 155 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10235164 |

